ارسل ملاحظاتك

ارسل ملاحظاتك لنا







استخدام نموذج Sherrod للتنبؤ بالفشل المالي : دراسة تطبيقية في الشركة العامة لصناعة الأدوية و المستلزمات الطبية في نينوى

العنوان بلغة أخرى: Using model Sherrod to measure the financial failure of a public company for the manufacture of medicines and medical supplies in Nineveh
المصدر: مجلة جامعة الأنبار للعلوم الاقتصادية والإدارية
الناشر: جامعة الأنبار - كلية الإدارة والاقتصاد
المؤلف الرئيسي: الحمداني، رافعة إبراهيم عبدالله (مؤلف)
المؤلف الرئيسي (الإنجليزية): Al-Hamdani, Rafiaa Ibrahim
مؤلفين آخرين: القطان، ياسين طه ياسين (م. مشارك)
المجلد/العدد: مج 5, ع 10
محكمة: نعم
الدولة: العراق
التاريخ الميلادي: 2013
الصفحات: 449 - 473
DOI: 10.34009/0782-005-010-020
ISSN: 1998-8141
رقم MD: 476765
نوع المحتوى: بحوث ومقالات
قواعد المعلومات: EcoLink
مواضيع:
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

160

حفظ في:
المستخلص: The financial failure of important topics and a serious impact on the goal of survival and continuity of companies it is the final stage of regression financial person may pass through companies where the goal to study the financial failure and its causes and measured using a model Sherrod, and has been selected public company for the pharmaceutical industry in Nineveh as company facing financial dilemmas and consecutive losses in recent years and for the purpose of applying the model on its financial activity to see stages of financial decline and the extent of exposure to the failure of financial research dependent on research group thrills promised research problems and the most important of which are : Is Sherrod model reveals the extent to which the company study sample for the risk of financial failure. The study assumed that the model shows us how the Company’s exposure to the risk of financial failure. The study found a set of conclusions, including : -There are several stages experienced by the company until they arrive to financial failure and regression phases include financial. -Model shows us Sherrod Company’s exposure to the pharmaceutical industry in the Nineveh risk of financial failure. The study concluded with proposals, including the need for alternative financial options enables the company to the pharmaceutical industry of the advancement of new and follow-up productive activities such as restoring financial restructuring, merger, entering into partial investments, and other .

ISSN: 1998-8141

عناصر مشابهة